Home Fifth Future Healthcare 100 Summit Unveils Full Agenda with 279 Speakers and 19 Forums Under the Theme 'The Computation of Life'

Fifth Future Healthcare 100 Summit Unveils Full Agenda with 279 Speakers and 19 Forums Under the Theme 'The Computation of Life'

Apr 06, 2021 08:00 CST Updated 08:00

From individual health to population hygiene, and from healthcare institutions and their industrial chains to the global medical and health ecosystem, the healthcare sector is undergoing an unprecedented wave of digitalization. With continuous breakthroughs, innovations, and convergence in biotechnology, information technology, new materials, and intelligent manufacturing, how should we reinterpret individual life and health? How can the intricate biological world be captured, interpreted, and computed?


April 16-18, 2021The 5th Future Healthcare 100 Conferencewill be"The Calculation of Life"as the theme, inSuzhou WujiangMeet with everyone.


版块结构_01.png

Conference Dates: April 16–18, 2021 (Friday–Sunday)

Venue:Suzhou · Wujiang · Le Méridien Hotel

Organizer:VCBeat, VB100, VCBeat Research Institute, Artery Orange

Co-organized by:Wujiang District People's Government, Guangdong Zhong Nanshan Medical Foundation

Co-organizers:Suzhou Wujiang Dongfang State-owned Capital Investment and Operation Co., Ltd.

Exclusive Strategic Partner:Alibaba Health

       

议程公布优惠.png

 (Scan the QR code to register and get an instant discount of 100 yuan)


19 Forums, Focusing on Future Trends, Industry Prospects, Global Perspectives, and Venture Capital Relations


16日趋势峰会-11.png


1. The summit will invite more than 30 government officials, scholars, investors, and entrepreneurs to explore the growth of China's general health industry around five major modules;


2、Academician of the Chinese Academy of Sciences, Fan Jia, President of Zhongshan Hospital Affiliated to Fudan University, Confirmed Attendance


3、Academician Zhang Zhiyuan, Chinese Academy of EngineeringConfirm attendance for the speech;


4、Member of the American Academy of Arts and Sciences, Member of the National Academy of EngineeringShiqing ChenConfirm attendance for the speech;


5、Dean of the School of Materials Science and Engineering, Suzhou University of Science and Technology; Academician of Academia EuropaeaLi ChangmingConfirmed attendance for the speech;


6、Top 5 Hospital PresidentsJointly explore new pathways and emerging demands in the digital transformation of hospitals;


7、5 Top Investment GurusExploring Investment Hotspots and Innovation Value in the Post-Pandemic Era


8、Alibaba Health, B-Soft, Sansure Biotech, GSK, MGI TechAwaiting guest confirmation of attendance.


TimeModuleAgendaGuest

Host: Professional Host
09:00-09:05Opening Ceremony AddressAddress at the ConferenceLi Datao | Founder of VCBeat
09:05-09:10Conference AddressFan Jia | Academician of the Chinese Academy of Sciences, President of Zhongshan Hospital, Fudan University
09:10-09:15Conference AddressWang Guorong | Deputy Secretary of the Wujiang District Committee of the Communist Party of China, and Mayor of the People's Government of Wujiang District
09:15-09:30Wujiang Global Promotion Led by LeadershipChen Jianzhong | Deputy District Mayor of Wujiang District People's Government
09:30-09:35Address at the ConferenceRelevant Leaders of the International Exchange and Cooperation Center, National Health Commission
09:35-09:45Conference AddressSun Baoqing | Chairman of the Guangdong Zhong Nanshan Medical Foundation
09:45-10:05External Variables:
Macro Environment and Future Trends
Trends in the Innovation and Development of Medical RobotsZhang Zhiyuan | Academician of the Chinese Academy of Engineering
10:05-10:25Development of the Healthcare System in the Era of Smart Health TrendsZhang Yuhui | Deputy Director of the Health Development Research Center, National Health Commission
10:25-10:45Leap in Computing Power:
Innovation in the Atomic World and the Bit World
The Calculation of LifeLi Datao | Founder of VCBeat
10:45-11:05A New Landscape of Internet Healthcare Driven by Cutting-Edge TechnologiesZhu Shunyan | Chairman and CEO of Ali Health
11:05-11:25
Applications of Brain Science, AI, and Intelligent Supercomputing in Future HealthcareShiqing Chen | Member of the American Academy of Arts and Sciences, Member of the U.S. National Academy of Engineering
11:25-11:45Innovative Applications of Biosensing in Medical DiagnosticsLi Changming | Dean of the School of Materials Science and Engineering, Suzhou University of Science and Technology; Member of Academia Europaea
Lunch Break
14:00-14:20Value Reconstruction: Digital Leap and Hospital TransformationBuilding Healthy Cities, Constructing Future CommunitiesGe Hang | Founder and Chairman of B-Health
14:20-14:40Opportunities and Challenges for Molecular Diagnostics in the Post-Pandemic EraDeng Zhongping | Deputy General Manager of Sansure Biotech
14:40-15:00Building a Digital Product Ecosystem Around Gene SequencersShan Riqiang | Chief Information Officer of MGI Tech
15:00-15:45New Pathways and Emerging Demands in the Digital Transformation of HospitalsHost: Jiang Tianjiao | Dean of VCBeat
Zhang Nuofu | Vice President of the First Affiliated Hospital of Guangzhou Medical University
Chen Hongxiang | Executive Vice President, Union Shenzhen Hospital of Huazhong University of Science and Technology (Nanshan Hospital)
Weng Jianping | Deputy Director of the Division of Life Sciences and Medicine, University of Science and Technology of China; President of Bengbu Medical College
Zhou Weikang | Deputy Director of Chongqing Hospital, University of Chinese Academy of Sciences
Tao Liang | President, Wuhan Asia Heart Hospital
15:45-16:30Scenario Validation: Industrial Iteration and Ecosystem TrendsHealthcare Industry Outlook: How to Enhance Quality of Life for More PeopleHost: Yu Wenxin | Chief Healthcare Analyst, Haitong Securities
Zhang Yuhui | Deputy Director of the Health Development Research Center, National Health Commission
Zhu Shunyan | Chairman and CEO of Alibaba Health
Wang Xinguang | Vice President, GSK China
Mystery Guest
16:30-17:15Investment Hotspots and Innovation Value in the Post-Pandemic EraModerator: Xu Xiaolin | Founder of Huagai Capital
Roundtable Guest: Wang Junfeng | Managing Director, Legend Capital
Xia Wu | Managing Director, CICC Capital
Li Yuhui | Founding Managing Partner and Chairman, Panlin Capital
Gan Shixiong | Founding Partner, Shengshan Asset



16个性化诊疗-11.png


1. VCBeat joins hands withGeneWisdomCo-hosted event, with over 10 senior executives from relevant industry companies attending to share insights, focusing on product and technological innovation to break through traditional boundaries;


2、Academician of the Chinese Academy of SciencesFan JiaConfirm attendance;


3、KingMed Diagnostics, BGI Group, Agilent Technologies, Huawei Cloud, ChenAn Bio, Rendong Medicine, Wondfo Biotechand other executives have confirmed their attendance


4、“2021 Blue Book of the Gene Industry”On-site release.


TimeAgendaGuest
HostHao Han | Senior Researcher at VCBeat
09:00-09:20AddressFan Jia | Academician of the Chinese Academy of Sciences
09:20-09:30Launch Ceremony of the "2021 Blue Book on the Gene Industry"Wang Liang | Founder & CEO, GeneHui
09:30-09:50Genetic Testing Enters Its Second Phase: How to Break Through Established Service Circles?Jin Ge | Founder and CEO of Rendong Medical Group
09:50-10:10How to Achieve Precision Prevention and Control of Infectious Diseases in the Post-Pandemic EraZhang Yong | Chief Scientist, Yuangu Ji; Visiting Professor, Guangzhou Institute of Respiratory Health
10:10-10:30Industry Focuses on the Downstream: The “Dark Horse” of Digital PCR Is Poised to Emerge!Cao Xinwei | Deputy General Manager of Raybiotech
10:30-11:10How Are Production Digitalization and the LDT Window Reshaping the Landscape of Molecular Diagnostics?Moderator: Wu Kai | Partner, Sinovation Ventures
Roundtable Guest: Guo Feng | Founder and CEO of Zhenzhun Bio
Kang Keren | Executive Vice President of Wondfo Biotech
Yang Wanfeng | Vice President of KingMed Diagnostics
Xiaowei Zheng | General Manager, Greater China, Agilent Technologies Diagnostics and Genomics Group
Shan Riqiang | Chief Information Officer, MGI Tech
Nie Junwei | Deputy General Manager, Life Sciences Division, Vazyme
11:10-11:30Single-Cell Technologies Move Toward the Clinic: Do We Need Such High Resolution?Ji Pengxiang | Vice President of Commercial Applications, ChenAn Biologics
11:30-12:10BT-IT Convergence: How to Compliantly Leverage Life Big Data and Empower Product R&D?Moderator: Wang Liang | Founder and CEO of Genetron Health
Roundtable Guest: Wang Jin | Co-founder, QiTan Technology
Yang Shuang | Executive Vice President, BGI Group
Meng Xin | Product Director, Huawei Cloud Medical AI Agent
Wang Tao | CTO, Ruipu Technology
Wang Chunxiao | Deputy General Manager, TreeGene Genetics


16医保科技-11.png


1. Invite experts in this fieldOver 10Unicorn companies and innovative enterprises shared their respective innovation achievements around topics such as commercial insurance, payment, medical insurance, and cross-sector collaboration, while discussing the significant challenges and opportunities facing innovative payment models;


2、Life Capital,Magi Health, Xiaoyusan, Baoxian Jike, U+ Health, Zhihui Shijue, Yuanxin HuibaoPending confirmation of attendance by distinguished guests.


TimeTopicGuest
HostJiang Guanjun | Partner, Mingde Actuarial
09:00-09:30Interpretation of Healthcare Insurance Reform Policies Under the 14th Five-Year PlanCai Jiangnan | Executive Chairman, Shanghai Chuangqi Health Research Institute
09:30-09:50Unprecedented Changes in a Century: New Opportunities in the Health Insurance Sector Through Deep Integration with Smart HealthcareZhang Boyuan | Executive Director, Life Capital
09:50-10:10Building a Complete Ecosystem from Payment to Services to Support the Development of a Multi-Tiered Medical Insurance SystemFeng Hao | General Manager, Innovative Payment and Patient Services Division, MedxHealth
10:10-10:30The Integration of Commercial Insurance Development with the Healthcare IndustryGuang Yao | Founder & CEO of Xiaoyusan Insurance Brokerage
10:30-10:50Entering the market through high-frequency medical insurance to build a [Healthcare + Insurance Payment] closed loopLi Shuo | Co-founder & COO of InsurGeek
10:50-11:10Managed Care Empowers Innovation in Health Insurance ProductsWang Yanping | Founder & CEO of U+ Health
11:10-11:30Assetization of Health Insurance Data and Big Data-Driven Integration of Healthcare and InsuranceJiao Long | COO, Knowledge Vision
11:30-11:50The Impact on and Opportunities for the Industry Behind the Gradual Standardization of City-Specific Inclusive Health InsurancePeng Xuan | CEO of Yuanxin Huibao



16数字疗法创新-11-11.png


1. CombinationPreparatory Committee for Digital Therapeutics Systems Engineering, China Association for Promotion of Rehabilitation Technology Translation and Development; Yuanyi CapitalCo-hosted, with premium resources powerfully aggregated;


2. China’s first industry forum focused on digital therapeutics,“2021 China Digital Therapeutics White Paper”First Release: An In-Depth Analysis of Why Digital Therapeutics Will Ultimately Become a Blue Ocean Market;


3、Takeda Pharmaceutical, Sanofi, Philips, MerckAwaiting confirmation of attendance from the Head of Innovation.


TimeTopicGuest
HostYang Ruirong | Partner at Yuanyi Capital
14:00-14:20Opening RemarksSong Wuchen | President-Elect and Executive Secretary-General, China Association for the Promotion of Rehabilitation Technology Translation and Development
14:20-14:40Analysis of the Development Prospects of Digital Therapeutics Globally and in ChinaLi Sirui | General Manager, Strategic Development Center, Tasly
14:40-15:00“2021 China Digital Therapeutics White Paper” ReleasedJiang Tianjiao | Dean of VCBeat
15:00-15:20How Digital Therapeutics Are Redefining Mobile HealthDong Yufang | Head of China, Takeda China Innovation Incubator & Digital Advisory Board
15:20-15:40The Development of Digital Therapeutics and Their Position in the Healthcare SectorXia Wenrong | Head of Innovation, Sanofi China
15:40-16:00Reflections on Disease-Specific Course-of-Illness Management Platforms and Digital TherapeuticsWan Ma | General Manager of Weimai AI Digital Therapeutics Center, Ph.D.
16:00-16:20Exploration and Practice of Digital Therapeutics: A Sharing SessionZhang Wei | Founder of Yongliu Technology
16:20-16:40Lessons from Abroad: International Experience in Digital TherapeuticsYang Ruirong | Partner at Yuanyi Capital
David Benshoof Klein | Co-founder and CEO of Click Therapeutics
Brent Vaughan | Cognito Therapeutics CEO
16:40-17:20Digital Therapeutics Reshape the Chronic Disease Management Ecosystem: What Are the Innovative Models for the Future?Moderator: Song Yiran | Investment Director, Yuanyi Capital
Li Yi | Acting Head of Merck China Innovation Center and Director of Innovation Incubation Investment
Liu Yunjiang | Founder and CEO of Yunkai Yamei
Zhang Wei | Founder of Yongliu Technology
Xia Wenrong | Head of Innovation, Sanofi China
Zhang Jing | Chairman and General Manager, Senmei Medical Technology
Dong Yufang | Head of China, Takeda China Innovation Incubator and Digital Advisory Board
17:20-18:00Opportunities and Challenges of Digital Therapeutics in Brain ScienceHost: Bi Yuanfeng | Co-founder and COO of VCBeat
Yongqin Zeng | Senior Director, Philips Ventures
Yan Jingjing | Founding Partner, Probe Capital
Zhang Zhiguang | Founder of AlsoLife
Wang Xiaoyi | CEO of Liuliu Brain, Ph.D.
Yongnan Ji | Director of Medical Applications, NVIDIA China
Ma Ke | Executive Director, Northern Light Venture Capital



16基层医疗-11.png


1. VCBeat in collaboration withBohou MedicalCo-hosted;


2. Aggregating digital services and product applications across multiple scenarios, fostering a new digital ecosystem for primary healthcare, etc.


TimeTopic DirectionGuest
HostZhang Ying | Executive Director, M&A Investment Department, GF Xinde
14:00-14:20New Infrastructure for Primary Healthcare in the Post-Pandemic EraLiao Xinbo | Former Deputy Director-General and Inspector of the Guangdong Provincial Health Department
14:20-14:40A Decade of Pharmaceutical Investment and the Next Ten Years: Opportunities in the Primary Healthcare MarketYu Wenxin | Chief Healthcare Analyst, Haitong Securities
14:40-15:00Benefits of International AccreditationMr. Michael Giuliano | International Executive Director, ACHS
15:00-15:20Digitalization-Led 3P Model Solves the Challenges of Chain Development in Primary HealthcareYan Honghui | Founder of BoHou Medical
15:20-15:40Digital Smart Operations Empowerment Service Platform for Primary HealthcareZhang Chenchen | CEO of Mingyi Zhonghe
15:40-16:00Building an All-Scenario Digital Platform to Enhance Patients’ Lifetime ValueJiang Yiru | Co-founder of YiHu Baijia
16:00-16:20Focusing on Digital Empowerment to Bridge the “Last Mile” of Public Health Physical ExaminationsJin Lei | CEO of Jianjian Family Doctor
16:20-16:40Innovation · Collaboration — Integrated Solutions Empowering Primary HealthcareGao Lei | Head of Feiying Business Marketing, Commercial & Business Development Department, AstraZeneca
16:40-17:20How to Open Up New Prospects for Primary Healthcare? Exploring a New Ecosystem of CollaborationModerator: Xie Kai | Partner, Fenxiang Investment Healthcare Fund
Roundtable Panelist: Zhang Suhua | Director, Institute of Social Medical Organizations, Shanghai Jiao Tong University
Cui Hongyu | General Manager of Innovation Technology, Omnichannel Business Unit, Microsoft (China) Co., Ltd.
Wang Lijue | Vice President of the China Pharmaceutical Material Association, Founder and Chairman of Akang Health Group
Xue Chong | Founder and CEO of Quanzhentong
Fan Minhua | Committee Member of the Party Committee, Jianggan District Health Commission, Hangzhou


17日战略峰会-11.png


1. InvitationTigermed, KingMed Diagnostics, New Horizon Health, GE Healthcare, BOE, DHC Software, Genetron HealthChairman of a benchmark listed company releases the annual corporate strategy;


2. InvitationKunyuan Bio, DXY, Haodf Online, Xinyi International, Shanzhen, Miao Health, Meiwei DentalRepresentative enterprises from healthcare industry unicorns and the Future Healthcare 100 will share their new technologies, new models, new scenarios, and new ecosystems in industrial innovation practices.


TimeSectionAgendaGuest
HostLiu Zongyu | Editor-in-Chief, VCBeat Content Center
09:00-09:20Leader's Perspective:
Listed Company Strategic Launch Event
Leading the Way, Leaping into the Future—Commercialization as the Core Competitiveness in the Second Half of China’s Pharmaceutical InnovationWang Ruwei | Deputy General Manager of Tigermed
09:20-09:40Exploration and Practice of KingMed Diagnostics 4.0Xie Jiangtao | Rotating COO, Vice President, and General Manager of the East China Region at KingMed Diagnostics Group
09:40-10:00How Far Is the Vast Frontier of Early Cancer Screening?Zhu Yeqing | Executive Director and CEO of New Horizon Health
10:00-10:20China's Digital + Healthcare Innovation Prescription: Comprehensive Domestic Production, Digital Empowerment, and Win-Win CooperationYan Hua | Vice President and Chief Marketing Officer, GE Healthcare China
10:20-10:40A New Ecosystem for Health Management in the Internet of Things EraZhang Wei | Senior Vice President of BOE, Co-CEO of the Smart Medical Engineering Business Group
10:40-11:00HOS: Building Next-Generation Smart Hospitals Through Digital TwinsWen Heng | Vice President of DHC Software Co., Ltd., Chief Consultant of DHC Medical
11:00-11:20Original Research Technology Empowers the Full Cycle of Precision Cancer Diagnosis and TreatmentXu Ce | CFO of Genetron Health
11:20-11:40The Future Is Here: Exploring How Integrated Financial Services Empower the Digital Transformation of the Healthcare IndustryZhu Min | General Manager, Medical Finance Department, Huarong Rongde Asset Management Co., Ltd.
Lunch Break
HostWang Guanglong | General Manager of Egg Yolk Tech VB100
14:00-14:20Calculating the Future:
The Path to Innovation for the Top 100 Enterprises
Seeing Is Believing: Reimagining the Future of Healthcare Through Innovative ServicesJiang Xiaodong | Managing Partner, Changling Capital
14:20-14:40How to Build Future Competitiveness for Early Cancer Screening ProductsZhang Jiangli | Founder and CEO of Genetron Health
14:40-15:00New Trends in the Digital Marketing Transformation of the Pharmaceutical Industry in the Post-Pandemic EraLi Tiantian | Founder of DXY
15:00-15:20What Is Truly “Patient-Centered” Internet Healthcare?Wang Hang | Founder and CEO of Haodf Online
15:20-15:40Cloud-Edge-Network Collaboration to Realize the Value of Intelligent Healthcare ServicesTai Congyue | Co-founder and President, Heart Doctor International
15:40-16:00Reflections and Practices in the Parental Health IndustryWu Hongxing | CEO of Shanzhen
16:00-16:20Empowering Insurance Upgrades Through Digital Health Management in the AIoT EraKong Fei | CEO of Miao Health
16:20-16:40
Julia Zhu | Founding Partner and CEO of Meiwei Dental
16:40-17:00Digital-Driven Upgrading and Innovation in Healthcare ServicesZhang Guodong | General Manager, Tencent Smart Healthcare


17药企数字化-11.png


1、"Report on Digital Marketing in Pharmaceutical Companies"Major Announcement;


2. Focus on hot topics: basic cloud infrastructure + digital solutions, the closed-loop of digital marketing for pharmaceutical companies, the upgrade of digital marketing driven by the pandemic, and the exploration of new retail models supported by cloud data, etc.


TimeAgendaGuest
HostHong Yuandong | Founder of Siqi Circle
09:00-09:20MNCs’ Digital Innovation Logic in ChinaMa Xi | Head of Market Access Innovation, Roche
09:20-09:40"Research Report on Digital Marketing in the Pharmaceutical Industry" ReleasedJiang Tianjiao | Dean of VCBeat Institute
09:40-10:00Digital Transformation of Pharmaceutical Marketing in the Post-Pandemic EraGao Jianfei | Founder & CEO of Yibai Technology
10:00-10:20Exploration of the New Retail Model Supported by Cloud DataDu Tongjie | Vice President of Quanyuantang
10:20-10:40How to Unlock the Maximum Value of Digital Marketing in the Pharmaceutical IndustryYan Guowei | Founder of Qingyun Technology
10:40-11:00Multi-Scenario, Omni-Channel Private Domain Traffic OperationsLai Gangbin | Founder of Jingli Technology
11:00-12:00Digital Marketing Upgrade Driven by Big DataHost: Wu Binghong | Founder of Yibei.com
Roundtable Guest: Ye Dan | President of Shiqiang Pharmaceutical
Ma Xi | Head of Access Innovation, Roche
Li Yingli | President of Souyao.com
Du Tongjie | Vice President of Quanyuantang



17高值耗材-11.png


1、BaiRen Medical, Terumo, MedtronicPending confirmation of attendance by guest representatives;


2. Focus on hot topics such as overseas markets and payment-side changes following volume-based procurement, independent innovation in high-value consumables, and the marketization of high-value consumables amid frequent policy updates.


TimeAgendaGuest
HostZhang Zhiling | Deputy General Manager, Shanghai Institute of Microsystem and Information Technology Industrial Research Institute
09:00-09:20Reflections on Innovation in High-Value Medical ConsumablesZhu Guoguang | Chief Analyst, Soochow Securities
09:20-09:40Volume-Based Procurement Becomes the Norm: How It Is Reshaping the High-Value Medical Consumables IndustryJin Lei | CEO of BaiRen Medical
09:40-10:00Practice of Coronary Functional and Imaging TechnologiesZheng Yuxiao | Head of Strategy and Expansion, Shenzhen Northcore
10:00-10:20Can the Neurointerventional Sector Replicate the Success of Cardiovascular Intervention?Zhao Zhong | Founder of ZC Medical
10:20-10:40Applications and Technological Innovations of High-Value Consumables in Sports MedicineLi Jianbo | Founder of Demei Medical
10:40-11:00Investment Layout and Logic for High-Value Medical Consumables Reaching New HeightsShi Yonghui | Managing Director, Medtronic China Fund
11:00-11:20Technological Innovation Practices of the CH-VAD Artificial HeartChen Chen | Chairman of Tongxin Medical
11:20-12:00# Where Is the Next Battlefield for Domestic Substitution in the First Year of the 14th Five-Year Plan?Moderator: Ding Guanhua | Vice President, Chende Capital
Roundtable Panelists:Chen Chen | Chairman of Tongxin Medical
Zhang Wen | General Manager, Terumo Cardiovascular Business Division
Li Jianbo | Founder of Demei Medical



17互联网医院-11.png


1、VCBeatCombinedDolphin Internet Healthcare Industrial ParkCo-hosted: An In-Depth Analysis of the Era of Internet Healthcare Licenses;


2. Focus on hot topics such as the differentiated competition among thousands of internet hospitals and the entry into a new phase of cooperation with physical hospitals;


3、White Paper on Internet Hospitals Specializing in AndrologyMajor Announcement.


TimeTopicGuest
HostZhang Xiaoxu | Senior Researcher, VCBeat
09:00-09:20The Creation and Exploration of the Internet + Medical Health Ecosystem in the Yinchuan ModelYuan Fang | Director, Information Department, Yinchuan First People's Hospital
09:20-09:40Analysis of the Current Cycle in the Internet Hospital IndustryTian Min | Partner at Yuanjing Capital
09:40-10:00The Dilemmas, Reflections, and Breakthroughs of Internet HospitalsYang Jianchun | Dean of Baidu Health Internet Hospital
10:00-10:20Introduction to the Chengdu Internet Healthcare Industrial ParkWu Hao | CEO of Taozi Internet Hospital
10:20-10:40White Paper on Internet Hospitals Specializing in Andrology ReleasedWang Chenhao | Researcher, VCBeat
10:40-11:00The Internet Healthcare Industry and Public Medical Resources: The Path to Balanced Dual WingsYue Yifeng | Vice Chairman and General Manager of Huaxi Public Utilities
11:00-11:20How Internet Healthcare Can Truly Enable Physicians to Realize Their Professional ValueChang Jiang | Founder of Umai Technology
11:20-12:00Development Positioning and Strategic Considerations for Internet Hospitals in China: Driven by Policy Guidance and Market ForcesModerator: Chen Qiulin | Deputy Director of the Health Industry Development Research Center, Chinese Academy of Social Sciences; Deputy President of Contemporary China Publishing House
Roundtable Panelist: Wu Fang | Assistant President of Yuanxin Technology Group · General Manager of Yuanxin Medical
Yang Jianchun | Dean of Baidu Health Internet Hospital
Wu Hao | CEO of Taozi Internet Hospital
Lu Tao | General Manager of Zhiben Internet Hospital



17科研成果转化-11.png


1. CombinationGuangdong Zhong Nanshan Medical Foundation, Chuangrui Investment, China Clinical Research Consortium, UK Beyond LabCo-hosted;


2. Supporting Organizations: Yarui Capital, Zhongguancun Zhiyou Scientist Fund, Tsinghua University Global Health Industry Innovation Center, Sichuan Western Medical Technology Transfer Center, Sichuan International Medical Exchange Promotion Association, Sinovation Ventures;


3. InvitationBeihang University, Tsinghua University, Sichuan University, University of Shanghai for Science and Technology, University of Oxfordguests from top-tier universities;


4. InvitationCleveland Clinic, Peking Union Medical College Hospital, West China Hospital, Xiangya Hospitalrepresentatives from top-tier hospitals.


TimeAgendaGuest
HostYin Xuejiao | Director, International Medical and Health Technology Transfer Platform, Yi Cu Hui
13:30-13:40AddressLi Datao | Founder of VCBeat
Han Wenxin | Co-Convenor and Secretary-General of the China Clinical Research Community
13:40-14:00Scientists and Angels: The Practice of Translating Scientific Achievements into Public ListingsWang Tianmiao | Professor, Beihang University
14:00-14:20CCI System Innovation Engine Incubating Nearly 100 Companies in 2021Tom Sudow | Director of Business Development, Cleveland Clinic Innovations
14:20-14:40The Path to Innovation in Joint Robotics, Focused on Clinical ValueLin Jin | Chief Physician, Department of Orthopedics, Peking Union Medical College Hospital
14:40-15:35Commercialization of Scientific Research Achievements from Top Institutions in China and the United StatesModerator: Tang Haofu | Chairman of Chuangrui Investment
Guest Speaker: Chongqing Medical University (Invitation Pending)
Lei Juan | Deputy Director, West China Transfer Center, West China Hospital, Sichuan University
Zhang Dawei | Dean of the Institute for Technological Development, University of Shanghai for Science and Technology
Sidney | Professor at Mount Sinai Hospital
Wang Tianmiao | Professor, Beihang University
15:35-16:15Exploration of a Complete Ecosystem Pathway: From Research and Findings to Translation and IndustrializationModerator: Geng Jia | Professor at Sichuan University, Distinguished Researcher at the State Key Laboratory of Biotherapy
Guest Speaker: Wang Jingjing | Executive Director, Global Health Industry Innovation Center, Tsinghua University
Ma Li | General Manager of New Nest
Huang Yangbin | General Manager and Dean, Wuhan Optics Valley Asia-Pacific Pharmaceutical Research Institute
Fang Li | Director of the Xiangya Medical Division, Intellectual Property Center of Central South University
16:15-16:35The Model of Technology Transfer and Commercialization at the University of OxfordJane Jin | Head of China, Oxford University Technology Transfer Office
16:35-16:55The Translational Story and Reflections Behind KeytrudaZhi Zhang | Business Development Manager, Technology Division, UK Medical Research Council
16:55-17:35Where Is the Path Forward for Scientists’ Innovation Models?Moderator: Ren Bobing | Executive Director, Sinovation Ventures
Guest Speaker: Zhangwei Luo | Chief Scientist, Suzhou Smart Healthcare Innovation Center; Former Chief AI Scientist, Siemens China Research Institute, Suzhou Branch
Yin Xuejiao | Director, International Medical and Health Technology Transfer Platform, Yicuhui
Sun Jingsheng | Executive Vice Chairman of the Clinical Trial Branch of the China Association for Medical Device Industry, Former Director of the Medical Device Registration and Supervision Division of the Beijing Municipal Drug Administration



17辅助生殖-11.png


1. VCBeat in collaboration withWeituo BiotechCo-hosted;


2、Research Report on the Assisted Reproductive Technology IndustryMajor Announcement.


TimeAgendaGuest
HostLu Qinchao | Founding and Managing Partner of Danlu Capital
14:00-14:30Interpretation of Regulatory Policies for the Assisted Reproductive Technology IndustryFan Yanjun | Assistant Director of the Center for Maternal and Child Health, Chinese Center for Disease Control and Prevention; Chair of the Special Committee
14:30-15:00Anchoring on Real Demand: Domestic Substitution and Industry Chain Empowerment—2021 Research on the Assisted Reproductive Technology IndustryShi Anjie | Senior Researcher, VCBeat
15:00-15:30The Path to Domestic Production of Medical Devices for Assisted Reproductive TechnologyLin Xiaozhen | Chairman of Weituo Bio
15:30-16:00New Business Models in Internet Healthcare for Assisted ReproductionSun Chunguang | Co-founder of Haoyunbang
16:00-16:30How Assisted Reproductive Technology (ART) Clinics Can Build Brand EquityHu Bo | Founder of Ciming Boao International Hospital
16:30-17:00New Opportunities for Investment and Development in the Assisted Reproductive Technology MarketLu Qinchao | Founding and Managing Partner of Danlu Capital


17数据智能-11.png


1. VCBeat in collaboration withVCBeat CapitalCo-hosted;


2. Focus on hot topics such as the development of data intelligence in the health industry, changes in traffic patterns, digital upgrades, and innovative collaboration models.


TimeAgendaGuest
HostLiu Zongyu | Editor-in-Chief, VCBeat Content Center
14:00-14:20The Path to Digital Transformation in Big Health Under the New Strategy of the Data IndustryTan Jianfeng | Member of the National Committee of the Chinese People's Political Consultative Conference, President of the Shanghai Information Security Industry Association
14:20-14:40New Payment, New Entry Point, New EcosystemZhao Yang | Partner, Weilai Capital
14:40-15:00By-Health's Path to E-commerce DigitalizationYin Xin | Chief Business Officer of By-Health
15:00-15:20Data Intelligence Ushers in a New Era of Health Insurance MarketingXiang Liang | Founder of Shuming Technology
15:20-15:40New Retail Era: How Prescription Drugs Can Break Through the WindXia Yu | Founder of Dekai Pharma
15:40-16:00Medical Device Ecosystem Innovation and Scenario Transformation Amidst Major Shifts in the Pharmaceutical IndustryKang Kai | Founder of Xiyu Health
16:00-16:20Private Domain Digital Intelligence Fuels the New Wave of Healthcare ConsumptionWei Zijun | Founder of Dianran Technology
16:20-16:40Huamei Haolian: Building a Chinese-Characteristic, Upgraded Version of UnitedHealth GroupXu Bingyu | Founder and CEO of Huamei Haolian
16:40-17:20How Data Intelligence Empowers the New Ecosystem Amid Payment Innovation and TransformationHost: Zhao Yang | Partner at Weilai Capital
Roundtable Guest: Tan Jianfeng | Member of the National Committee of the Chinese People's Political Consultative Conference, President of the Shanghai Information Security Industry Association
Yin Xin | Chief Business Officer of By-Health
Xiang Liang | Founder of Shuming Technology
Xia Yu | Founder of Dekai Pharmaceutical
Kang Kai | Founder of Xiyou Health
Wei Zijun | Founder of Dianran Tech



17LPGP峰会-11.png


1. VCBeat andYangtze River Delta Integration Demonstration Zone (Suzhou) Venture Capital Service Co., Ltd.Co-hosted;


2. Provide GPs with opportunities for in-depth, face-to-face exchanges with global LPs.Warm reminder: This summit is a closed-door event, requiring separate registration and approval.


TimeSectionAgendaGuest
HostYan Jingjing | Founder, Probe Capital
09:30-09:40Guest SpeechAddressDeputy District Mayor of Wujiang District in charge
09:40-10:00Boiling YearsInsights into the Changing Times: The Next Decade of Healthcare Investment in China (Tentative)Wu Xia | Managing Director, CICC Capital
10:00-10:50Reconstructing AestheticsDiscussing the Chinese-Style LP-GP Relationship: The Healthcare SectorHost: Xu Hong | Partner, Heju Yinuo Grand Health Industry Fund
Zhang Yanhong | Deputy Secretary of the Party Committee and General Manager of Suzhou Wujiang Dongfang State-owned Assets
Wang Xiaohui | Managing Partner, Shengjing Jiacheng Fund of Funds
Hu Chuanwei | Vice President, Hengqin Jintou Group
Li Yuhui | Founding Managing Partner, Panlin Capital
Yu Zhengkun | Founding Partner of Jifeng Capital
Tea Break
11:00-11:35Specialized RoadshowTang Haofu | Managing Director, Chongqing Dianshi Chuangjian Fund Management
Lunch & Lunch Break
14:00-14:20The Intelligent InvestorR&D-Driven Investment in BiosciencesLiu Yu | Managing Partner, BGI Win-Win
14:20-15:10The Great GameReview of the 2020 IPO Market for Healthcare Companies and Future OutlookModerator: Luo Jiarong | Chief Analyst, GF Securities
Zhou Yi | Partner, SCGC Health Industry Fund
Li Jiangfeng | Partner and Managing Director, Fortune Star Medical Fund
Ma Ke | Executive Director, Northern Light Venture Capital
Xu Ce | Chief Financial Officer of Genetron Health
Tea Break
15:20-16:10The Singularity Is NearThe Debate on CVC Investment in HealthcareModerator: Xu Qian | Partner at DT Capital Partners
Yang Ce | General Manager, Investment, Alibaba Health
Hou Xiaoxi | General Manager, Haier Medical Fund
Wu Aimin | Partner and President, Sinopharm Capital
Li Fan | Partner and Managing Director, Fosun Venture Capital
Zhou Hui | General Manager, Ping An Ventures
16:10-17:00How to Build a New Healthcare Ecosystem Integrating Industry and Finance?Moderator: Cao Yun | Director of Investor Relations, Shengshan Asset Management
Gu Yan | Party Secretary and Chairman of the Board, Suzhou Wujiang Dongfang State-owned Assets Supervision and Administration Commission
Gan Shixiong | Founding Partner, Shengshan Capital
Xu Daqiang | Chief Business Officer, WuXi Biologics Group
Li Datao | Founder of VCBeat
17:00-17:40Closed-Door Exchange



18国际峰会-11.png


1. VCBeat in collaboration withUK Beyond Laboratory, Huanyu Health, MSQCo-hosted;


2、UK, US, Canada, Belgium, Germany, Middle Eastoverseas experience in industrial development;


3、Microsoft, Intel, Amazon, IBM, Hims & Hers, Insilico, Viome,Livongo & VivanteSenior executives from high-quality overseas enterprises have confirmed their attendance.


TimeSectionAgendaGuest
HostQi Hong Bu | VCBeat Overseas Advisor
9:00-9:05Conference AddressAddressLi Datao | Founder of VCBeat
9:05-9:25Digital Healthcare Empowerment and PracticeThe Global Frontier of Pharmaceutical Innovation and China’s ChallengesWang Gang | Chief Scientist, Greater China, Clarivate
9:25-9:45Co-building a Digital Healthcare Cloud Ecosystem to Empower Chinese Healthcare Enterprises in Going GlobalTao Ran | General Manager, Commercial Cloud Solutions, Microsoft Greater China
9:45-10:10AI-Empowered Digital Transformation and Innovation in Pharmaceutical CompaniesModerator: Bi Yuanfeng | Co-founder of VCBeat
Li Jian | Head of Intel’s Healthcare and Life Sciences Innovation Business, Asia-Pacific
Huang Qingchun | Director of Healthcare and Life Sciences, Amazon AWS
10:10-10:30AI Accelerates New Drug DevelopmentRen Feng | Chief Scientific Officer, Head of Drug Discovery at Insilico Medicine
10:30-10:50How to Promote Better Patient Engagement in Decentralized Clinical TrialsChing Tian | Senior Vice President, Medable
10:50-11:10Advances and Challenges in Personalized Nutrition and HealthNaveen Jain | Founder and Chairman of Viome
11:10-11:30Current Status and Future of Digital TherapeuticsInnocent Clement | Founder of Ciba Health
11:30-12:10Trends in the Development of Health and Medical TechnologyHost: Bu Qihong | VCBeat Overseas Consultant
Kimon Angelides | Founder of Livongo & Vivante
Sandeep Makhijani | Head of IBM Watson Health, Asia Pacific
Leon Leong | Fenda Smart Technology CEO & Spring Ventures CEO
Patrick Carroll | Chief Medical Officer, HIMS&HERS
Lunch Break
14:00-14:20Global Regional Economic InnovationOverview of the Biopharmaceutical Industry and Investment Opportunities in Flanders, BelgiumBart Boschmans (Lin Bosen) | Consul for Flanders Business, Consulate General of Belgium in Shanghai
14:20-14:40Ontario, Canada – The Gateway to North American Life SciencesSong Yijun | Canadian Consul in China & Chief Representative of Ontario in China
14:40-15:00Practical Experience in the Transfer of Technological Innovations in Asian Medical Research in CanadaChen Fangxia | Director of Business Development, Asia Technology Transfer Centre, Western University, Canada
15:00-15:20Acceleration and Ecosystem Building for China-Canada InnovationWang Tong | Co-Founder, China-Canada Angel Alliance and Zhongguancun Dahe Capital
15:20-15:40Europe’s Premier Hub for Investment and Collaboration in the Pharmaceutical and Healthcare IndustriesXu Jun | Executive Chief Representative, Nanjing Office of Germany’s North Rhine-Westphalia International Business Agency
15:40-16:00Digital Healthcare Ecosystem and Development Trends in the Middle EastLouiza Chitour | Project and Partnership Manager, Plug and Play Tech Center
16:00-16:40Discussion on the Digital Innovation Development and Trends in the Pharmaceutical IndustryXiaoan Daxia | MSQ Partner
Tan Yan | CEO of Xbiome
Zeng Hainian | CEO, Suikun Intelligent Technology
Chen Chi | Chairman of BayHelix Group
Zhou Lei | Chairman of Huanyu Health Group
Guowei Su | Vice President, Greater China Region, SmileDirectClub (SDC)
Zhu Huaxing | Chairman of Nearshore Protein
16:40-17:00How AI Empowers Personalized Diagnosis and TreatmentMichael Wilkinson | CEO and Founder of Inavya
17:00-17:20Current Status of Digital Healthcare Development in the UK and the Extensive Impact of Digital Medical TechnologiesNick Rodgers | Chairman of the South East Academic Health Science Network, UK; Chairman of Destiny Pharma
17:20-17:40The Digital Wave in Healthcare and Life SciencesHilary Thomas | KPMG UK Chief Medical Advisor
17:40-18:00R&D of New Drugs for Rare Diseases and China-UK CooperationZhou Lu | CEO, UK Beyond Lab



18智慧医院-11.png


1. VCBeat Joins Hands withJD HealthCo-hosted;


2、Smart Hospital HIS Industry Research ReportMajor Announcement;


3. Explore hot topics such as next-generation HIS systems, cloud computing, hospital cloud migration, and smart hospital service ratings.


TimeTopicGuest
HostZheng Yufen | Founder of Yueyin Medical Fund
09:00-09:20Practice and Exploration of the Operational Models of Traditional Chinese Medicine Hospitals in the Internet EraRen Xianqing | Vice President, The First Affiliated Hospital of Henan University of Chinese Medicine
09:20-09:40Exploration of Models for Hospital Smart Management Construction Under the New ParadigmWei Xuejie | Vice President of the General Hospital of Xuzhou Mining Group
09:40-10:00Exploration and Practice of Cloud-Native Regional IntegrationHong Xiaoqing | Director, Lianzhong Consulting
10:00-10:15Embracing Change and Adaptability: Reflections on the Informatics Needs of Primary HealthcareYin Hong | Deputy Director of the Education, Health and Sports Bureau (Medical Security Administration) of Xixian New Area, Shaanxi Province; Director of the Public Health Management Center of Xixian New Area
10:15-10:30The Path to Healthy Cities: Internet-Empowered Construction of New Scenarios for Primary HealthcareLiu Mingyan | General Manager of JD Health's Healthy Cities Division
10:30-10:50Future Exploration of the Smart Medical Community PlatformZhou Zanhe | Founder and Chairman of Heyu Health
10:50-11:10Data-Intelligence Driven: Building a New Ecosystem for Smart HealthcareWang Dongyuan | General Manager, Smart Healthcare, JD Health
11:10-11:25“Smart Hospitals Drive Comprehensive Transformation of Hospital Architecture, Hospital Information Management System Restructuring Underway—Research on the New Generation HIS Industry” Report ReleasedZhao Hongwei | Senior Researcher at VCBeat
11:25-12:00Reflections on the Future Form of Smart Hospitals in the Wave of DigitalizationModerator: Chen Yusi | Senior Investment Manager, GGV Capital
Roundtable Panelist: Wang Dongyuan | General Manager, JD Health Smart Healthcare
Ye Xin | Deputy Dean, Yilianzhong Beijing Research Institute
Zhou Zanhe | Founder and Chairman of Heyu Health



18健康管理-11.png


How Can the Health Management Industry Create Opportunities and Meet Challenges Amidst the Trend of Chronic Diseases Affecting Younger Populations, an Aging Population, and Intensifying Market Competition?


TimeAgendaGuest
HostYu Jurong | CFO and Board Secretary of Yibao Health, Partner at Heju Yinuo Big Health Industry Fund
09:00-09:20The “Chinese Model” of Internet+ Chronic Disease ManagementYang Wenlin | CPO and Group Vice President of Zhiyun Health
09:20-09:40“Health Services + Insurance Products” Model Empowers Innovative Practices in the Core Insurance BusinessLi Qi | Deputy General Manager, Pacific Healthcare Management Co., Ltd.
09:40-10:00Algorithm-Driven Dual-Channel Healthcare Model Leads the New Wave of Medical and Health InnovationWang Xu | Deputy General Manager of iKang Group and Deputy General Manager of Daoyitong Operations
10:00-10:20Deepening Smart Health to Foster a New Paradigm for Urban Health Industry DevelopmentLi Yuxin | Founder and Chairman, Health Benefit
10:20-10:40Big Data-Enabled New Model for Full-Course Traditional Chinese Medicine Health ManagementCao Xueli | CEO of Shangyi Renjia
10:40-11:00IoT-Driven Innovation in Home Healthcare ServicesMa Ji | Co-Founder and Chief Medical Officer of Yilianjia Platform
11:00-11:20The Future of Smart, Precision Management of Chronic Respiratory DiseasesPan Tao | Co-Founder of Huichang CloudMed
11:20-12:00Surging Trends: Opportunities and Challenges in Industrial LeapfroggingModerator: Yu Jurong | CFO and Board Secretary of Yibao Health, Partner at Heju Yinuo Big Health Industry Fund
Roundtable Guest: Liu Yan | Founder of Anhe Health
Wang Xu | Deputy General Manager of iKang Group and Deputy General Manager of Operations at Daoyitong
Li Shuo | Co-founder & COO of Insurance Geek
Yue Hongwen | President of Boao Yiling Cardiovascular Hospital
Cao Xueli | CEO of Shangyi Renjia
Li Yuxin | Founder and Chairman of HealthBenefit



18-ITBT-11.png


1. VCBeat Partners with5Y CapitalCo-hosted, Defining ITBT;


2. Focus on hot topics such as the application of AI in new drug development and the emergence of next-generation application categories.


TimeAgendaGuest
HostZeng Ying | EIR (Entrepreneur in Residence) at Source Code Capital
09:00-09:255Y Capital’s ITBT Investment Practice: Why We Are Firmly Bullish on Digital Drug R&D?Jing Xutian | Managing Director, Wuyuan Capital
09:25-09:50Drug Innovation Driven by Digitalization and IntelligenceWen Shuhao | Co-founder and Chairman of XtalPi
09:50-10:15Implementation and Value of Digital Transformation in Clinical R&D for Pharmaceutical CompaniesMa Dong | Partner at Taimei Medical Technology
10:15-11:00How Can Computation and AI Break Through the Traditional Paradigm of New Drug Development?Moderator: Li Yang | Founder and CEO of Anji Kang'er
Li Chengtao | Founder & CEO of StarryPharm Technology
Lai Caida | CEO of METiS Pharmaceuticals
Chen Hang | Co-founder and CEO of Xingkangyuan Biology
11:00-11:40Next-Generation Computing + Experimentation: The Emergence of New Application CategoriesHost: Wen Wen | Founder and CEO of Huanyi Bio
Guest: Tan Yan | CEO of XBiome
Wang Yuchong | Founder and CEO of ChenAn Biologics
Ji Xuwu | Founder of Purui Benchmark Technology
Qian Weiwen | Deputy General Manager of Wu Gan Pharmaceutical
11:40-12:00"Regulatory Implementation: Comprehensive Application from Pharmaceuticals to Medical Devices—Industry Research on Real-World Studies"Hao Han | Senior Researcher, VCBeat



18医美行业-11.png


1. VCBeat Joins Hands withMingfeng CapitalCo-hosted by the Leading Medical Aesthetics CompanyAimei KeConfirm attendance;


2. Focus on hot topics such as emerging biotech players and breakthroughs in new materials, the hair transplantation and body contouring markets, and platform competition in the era of mass-market adoption of non-surgical medical aesthetics.


TimeAgendaGuest
HostHu Xuan | Senior Analyst, VCBeat
13:30-13:50Value Distribution in the Medical Aesthetics Industry ChainJin Xuekun | Founding Partner, Mingfeng Capital
13:50-14:10Lessons from Abroad: Insights from Global Aesthetic Medicine Industry Experience for Investment in China’s Aesthetic Medicine MarketChen Long | Head of Investment, Imeik
14:10-15:00New Breakthroughs in Upstream Technologies and Materials for the Medical Aesthetics Industry, Along with Investment RationaleModerator: Fei Simin | Partner at Mingfeng Capital
Roundtable Guest: Wang Zhen | Partner, Mingfeng Capital
Yan Jingran | Executive Director, Honghui Capital
Song Gaoguang | Partner, Northern Light Venture Capital
Lin Lei | General Manager, CCB International Healthcare Growth Fund
15:00-15:50The Medical Aesthetics Body Contouring Market Is Poised for an Explosive Boom: How Can Medical Aesthetics Service Providers Seize the Opportunity?Moderator: Hu Xuan | Senior Analyst, VCBeat
Guest: Li Yong | Managing Director, Chengdu Badachu
Zhao Heng | General Manager, Langzi Medical Aesthetics
15:50-16:10The "Future" Market of Hair Transplantation in ChinaLi Xingdong | Founder of Daimai Micro-needle Hair Transplant Global Chain Hospitals
16:10-16:30AI-Powered SaaS Solutions Drive the Development of the Traditional Medical Aesthetics IndustryLiu Hongyu | Operations Director and Chief Traffic Officer, Lanshi Technology
16:30-16:50Dissolving Microneedle Drug Delivery Technology and IndustrializationJiang Lin | Founder of Qinglan Bio



18肿瘤早筛-11.png


1. VCBeat joins hands withEarly Screening NetworkCo-hosted, with deeply specialized topics


2、2021 Report on the Early Cancer Screening IndustryMajor Announcement;


3、BGI Group, Dian Diagnostics, Rendong Medicine...and other corporate executives have confirmed their attendance.


TimeTopicGuest
HostChen Zanquan | CEO/Co-founder of Zaoshai.com
13:30-13:50Investment Hotspots and Value Amidst Industry LeapfroggingZhou Quan | Managing Director, Legend Capital
13:50-14:10Technological Development and Innovation Directions in Early Cancer ScreeningZhu Shida | Commander-in-Chief of BGI's Domestic "Fire Eye Laboratory," Director of BGI's R&D Center, and Head of the Oncology Business Unit
14:10-14:30Emerging Giants, Product Upgrades—2021 Industry Report on Early Cancer ScreeningWang Shiwei | Researcher at VCBeat
14:30-14:50China’s Early Cancer Screening Program Based on HIFI TechnologyZhou Jun | CEO, Herui Gene
14:50-15:10Application of DNA Methylation Detection Technology in Early Cancer Screening ProductsZhang Lianglu | Founder and General Manager of Amison
15:10-15:30From Detection to Early Screening: Business ExplorationYan Linghua | CEO of Tree Genetics
15:30-15:50Early Screening and Prognostic Diagnosis of Bladder CancerChen Gang | Founder and CEO of Kanglu Bio
15:50-16:10Research on Integrated Solutions for Precision Diagnosis and Treatment of Early-Stage Lung Cancer Based on Domestic Electromagnetic Navigation SystemsYi Xin | Chairman and General Manager of Suzhou Langkai Medical
16:10-17:00New Opportunities in the Blue Ocean Market for Early Cancer ScreeningChen Zanquan | CEO/Co-founder of Zaoshai.com
Shen Qin | Partner at Shengyu Investment
Zhu Shida | Commander-in-Chief of BGI’s “Fire Eye Laboratory” in China, Director of BGI’s R&D Center, and Head of the Oncology Business Unit
Jiang Tang | Senior Vice President and Chief Strategy Officer, Dian Diagnostics
Zhu Ruixin | Vice President of Bioinformatics, Rendong Medical Group
Yan Linghua | CEO of Tree Genetics


议程公布优惠.png

(Scan the QR code to register and get an instant discount of 100 yuan)